Print

HVTN 111

NCT02997969

Trial Details:

I Ongoing
HIV Vaccine Trials Network; IPPOX Foundation; Novartis Vaccines
DNA-HIV-PT123,Protein/MF59 vaccine
Healthy adults
RandD/trials/Lists/ClinicalTrialsList
9/1/2017
DNA clade C ZM96 gag, 2) clade C ZM96 gp140, and 3) clade C CN54 pol-nef; Protein clade C TV1.C gp120 Env and clade C 1086.C gp120 Env
DNA-HIV-PT123 vaccine in the left deltoid at months 0, 1, 3, and 6. They will receive placebo in the right deltoid at months 0 and 1, and the Protein/MF59 vaccine at months 3 and 6. OR DNA-HIV-PT123 vaccine in the left deltoid at months 0, 1, and 6. They